Management of hyperlipidaemia

Authors

  • A D Marais Division of Chemical Pathology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, South Africa
  • D J Blom Division of Lipidology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
  • F J Raal Carbohydrate and Lipid Metabolism Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Division of Endocrinology and Metabolism, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

DOI:

https://doi.org/10.7196/SAMJ.2024.v114i3.1964

Keywords:

hyperlipidaemia, management

Abstract

-

References

Hyperlipidaemia. In: McMillan CR, ed. PMB-X Guidelines 2023. Vol. 6. Johannesburg: New Media, 2023:53-56. https://medicalacademic.co.za/issues/2023/pmbx2023/ (accessed 18 April 2023).

Klug EQ, Raal FJ, Marais AD, et al. South African dyslipidaemia guideline consensus statement: 2018 update. A joint statement from the South African Heart Association (SA Heart) and the Lipid and Atherosclerosis Society of Southern Africa (LASSA). S Afr Med J 2018;108(11b):973-1000. https://doi. org/10.7196/SAMJ.2018.v108i11.13383

Klug EQ, Raal FJ. New cholesterol targets for patients at high or very high cardiovascular risk and the indications for PCSK9 inhibitors. S Afr Med J 2020;110(11):1059. https://doi.org/10.7196/SAMJ.2020. v110i11.15191

Marais AD, Blom DJ, Raal FJ. Familial hypercholesterolaemia in South Africa: A reminder. S Afr Med J 2021;111(8):700-701. https://doi.org/10.7196/SAMJ.2021.v111i8.15782

Downloads

Published

2024-03-18

Issue

Section

Correspondence

How to Cite

1.
Marais AD, Blom DJ, Raal FJ. Management of hyperlipidaemia. S Afr Med J [Internet]. 2024 Mar. 18 [cited 2024 Apr. 21];114(3):e1016. Available from: https://samajournals.co.za/index.php/samj/article/view/1964

Similar Articles

1-10 of 53

You may also start an advanced similarity search for this article.